Similar articles

• IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.

  Hentrich M, Fehnle K, Ostermann H, Kienast J, Cornely O, Salat C, Ubelacker R, Buchheidt D, Behre G, Hiddemann W, Schiel X. Hentrich M, et al. Crit Care Med. 2006 May;34(5):1319-25. doi: 10.1097/01.CCM.0000215452.84291.C6. Crit Care Med. 2006. PMID: 16540956 Clinical Trial.
• To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock.

  Neugebauer EA. Neugebauer EA. Crit Care Med. 2007 Dec;35(12):2855-6. doi: 10.1097/01.CCM.0000295277.26957.65. Crit Care Med. 2007. PMID: 18043203 No abstract available.
• Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.

  Laupland KB, Kirkpatrick AW, Delaney A. Laupland KB, et al. Crit Care Med. 2007 Dec;35(12):2686-92. Crit Care Med. 2007. PMID: 18074465 Review.
• [Management of septic shock and acquired respiratory distress syndrome in pediatric cancer patients].

  Bindl L, Nicolai T. Bindl L, et al. Klin Padiatr. 2005 Nov;217 Suppl 1:S130-42. doi: 10.1055/s-2005-872507. Klin Padiatr. 2005. PMID: 16288359 Review. German.
• Septic shock: current concepts.

  Brampton WJ. Brampton WJ. Br J Hosp Med. 1997 Feb 19-Mar 4;57(4):127-9. Br J Hosp Med. 1997. PMID: 9166369 No abstract available.